Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Hemodynamics and Inflammation in Decompensated Cirrhosis
NCT01769040Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in Liver cirrhosis (LC), ascites, sponsored by Rigshospitalet. Started Nov 2012; status: completed.
02
Drugs
rifaximin
03
Conditions
Liver cirrhosis (LC)ascites
Beyond the preview
Go deeper on NCT01769040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769040.